|
Therapeutic
Area
|
Product
/ Brand Name
|
Indication
|
| |
|
|
| Transplantation |
CellCept®
(mycophenolate mofetil) |
The Prophylaxis of acute organ
rejection & treatment of refractory organ rejection
in patients receiving allogeneic renal transplant, increased
graft & patient survival receiving allogeneic cardiac
trasnplant & used Concommitently with Cys & corticosteriods.
|
| |
Cymevene®
(ganciclovir) |
Cytomegalovirus infection
|
| |
Recormon®
(epoetin beta ) |
For the treatment of Anemia
|
| |
Zenapax®
(daclizumab) |
The Prophylaxis of acute organ
rejection in patient receiving renal transplants.
|
| |
(Valcyte®
valganciclovir) |
Treatment
of cytomegalovirus (CMV) retinitis in AIDS patients and
prevention of CMV disease in solid organ transplant patients
at high risk.
|
Currently distributed in India
by:-
Taksal Pharma Pvt. Ltd.
9-10/3, Asaf Ali Road
Laxman House, Ground Floor
New Delhi 110 002
Tel. +91 11 23240071-74
+91 11 30128001-4
Fax +91 11 23240075
